Latest Breaking News On - பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் சாரா கில்பர்ட் - Page 1 : comparemela.com

Vaccitech was valued at $ 579 million in the U.S. public offering Vaccitech, the owner of the technology behind the Oxford / AstraZeneca coronavirus vaccine, raised $ 111 million through its initial public offering on Thursday, close to its original expectations and ready for investors to address recent concerns about rare side effects. . The company priced it at $ 17 before it was listed on the Nasdaq, halfway through its projected price range. At the offer price, Vaccitech would be worth $ 579 million, 36 percent above its set price. the last private fundraiser in March. Vaccitech was founded in 2016 by scientists from the University of Oxford Sarah Gilbert and Adrian Hill and is sponsored by Tencent, Google Ventures and California’s Gilead Sciences biotechnologies.

United statesOxford astrazenecaVaccitech oxford astrazenecaHargreaves lansdownAdrian hillWilliam blairMorgan stanleyCalifornia gilead sciencesUniversity of oxford sarah gilbertOxford sarah gilbertGoogle venturesGilead sciencesVaccitech oxfordஒன்றுபட்டது மாநிலங்களில்ஹார்‌க்ரீவ்ஸ் ல்யாந்ஸ்ட்வ்ந்வில்லியம் பிளேயர்